{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T20:59:12Z","timestamp":1790283552687,"version":"4.1.0"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003009","name":"Science Technology & Innovation Funding Authority","doi-asserted-by":"publisher","award":["34789"],"award-info":[{"award-number":["34789"]}],"id":[{"id":"10.13039\/501100003009","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimie"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.biochi.2026.09.010","type":"journal-article","created":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T23:49:35Z","timestamp":1789602575000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["NFYA regulates the expression of CD44 via binding to upstream cis-element in breast cancer cells"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6811-431X","authenticated-orcid":false,"given":"Sohair","family":"Salem","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaymaa M.M.","family":"Yahya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.biochi.2026.09.010_bib1","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"issue":"15","key":"10.1016\/j.biochi.2026.09.010_bib2","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1038\/s41388-022-02239-4","article-title":"Effective targeting of breast cancer stem cells by combined inhibition of Sam68 and Rad51","volume":"41","author":"Turdo","year":"2022","journal-title":"Oncogene"},{"issue":"7","key":"10.1016\/j.biochi.2026.09.010_bib3","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a036905","article-title":"Cancer stem cells and epithelial-to-mesenchymal transition in cancer metastasis","volume":"10","author":"Celia-Terrassa","year":"2020","journal-title":"Cold Spring Harb. Perspect. Med."},{"issue":"1","key":"10.1016\/j.biochi.2026.09.010_bib4","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/stem.563","article-title":"Aldehyde dehydrogenase activity of breast cancer stem cells is primarily due to isoform ALDH1A3 and its expression is predictive of metastasis","volume":"29","author":"Marcato","year":"2011","journal-title":"Stem Cell."},{"issue":"9","key":"10.1016\/j.biochi.2026.09.010_bib5","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.5966\/sctm.2015-0048","article-title":"Concise review: emerging role of CD44 in cancer stem cells: a promising biomarker and therapeutic target","volume":"4","author":"Yan","year":"2015","journal-title":"Stem Cells Transl. Med."},{"key":"10.1016\/j.biochi.2026.09.010_bib6","article-title":"The importance of CD44 as a stem cell biomarker and therapeutic target in cancer","volume":"2016","author":"Thapa","year":"2016","journal-title":"Stem Cell. Int."},{"issue":"11","key":"10.1016\/j.biochi.2026.09.010_bib7","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0050867","article-title":"Cell specific CD44 expression in breast cancer requires the interaction of AP-1 and NFkappaB with a novel cis-element","volume":"7","author":"Smith","year":"2012","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.biochi.2026.09.010_bib8","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41581-022-00636-2","article-title":"Advances in CRISPR therapeutics","volume":"19","author":"Chavez","year":"2023","journal-title":"Nat. Rev. Nephrol."},{"issue":"5","key":"10.1016\/j.biochi.2026.09.010_bib9","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s00109-020-01893-z","article-title":"Mitigating off-target effects in CRISPR\/Cas9-mediated in vivo gene editing","volume":"98","author":"Han","year":"2020","journal-title":"J. Mol. Med. (Berl.)"},{"issue":"22","key":"10.1016\/j.biochi.2026.09.010_bib10","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gku936","article-title":"Easy quantitative assessment of genome editing by sequence trace decomposition","volume":"42","author":"Brinkman","year":"2014","journal-title":"Nucleic Acids Res."},{"issue":"3","key":"10.1016\/j.biochi.2026.09.010_bib11","doi-asserted-by":"crossref","DOI":"10.3390\/cells13030261","article-title":"Systematic comparison of computational tools for sanger sequencing-based genome editing analysis","volume":"13","author":"Aoki","year":"2024","journal-title":"Cells"},{"issue":"4","key":"10.1016\/j.biochi.2026.09.010_bib12","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0124633","article-title":"CCTop: an intuitive, flexible and reliable CRISPR\/Cas9 target prediction tool","volume":"10","author":"Stemmer","year":"2015","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.biochi.2026.09.010_bib13","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1093\/nar\/gkx1268","article-title":"Refined sgRNA efficacy prediction improves large- and small-scale CRISPR-Cas9 applications","volume":"46","author":"Labuhn","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.biochi.2026.09.010_bib14","article-title":"Drug efflux transporters are overexpressed in short-term tamoxifen-induced MCF7 breast cancer cells","volume":"2016","author":"Krisnamurti","year":"2016","journal-title":"Adv. Pharmacol. Sci."},{"issue":"9","key":"10.1016\/j.biochi.2026.09.010_bib15","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1101\/gr.136127.111","article-title":"Linking disease associations with regulatory information in the human genome","volume":"22","author":"Schaub","year":"2012","journal-title":"Genome Res."},{"issue":"9","key":"10.1016\/j.biochi.2026.09.010_bib16","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1101\/gr.139105.112","article-title":"Sequence features and chromatin structure around the genomic regions bound by 119 human transcription factors","volume":"22","author":"Wang","year":"2012","journal-title":"Genome Res."},{"key":"10.1016\/j.biochi.2026.09.010_bib17","article-title":"Sequence features associated with the cleavage efficiency of CRISPR\/Cas9 system","volume":"6","author":"Liu","year":"2016","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.biochi.2026.09.010_bib18","doi-asserted-by":"crossref","DOI":"10.3390\/genes14040806","article-title":"CRISPR\/Cas9 gene editing system can alter gene expression and induce DNA damage accumulation","volume":"14","author":"Yang","year":"2023","journal-title":"Genes"},{"issue":"1","key":"10.1016\/j.biochi.2026.09.010_bib19","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.bbrc.2020.04.145","article-title":"CRISPR-Cas9 gene editing causes alternative splicing of the targeting mRNA","volume":"528","author":"Zhang","year":"2020","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.biochi.2026.09.010_bib20","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s12896-018-0472-8","article-title":"CRISPR\/Cas9-mediated genome editing induces gene knockdown by altering the pre-mRNA splicing in mice","volume":"18","author":"Tang","year":"2018","journal-title":"BMC Biotechnol."},{"issue":"1","key":"10.1016\/j.biochi.2026.09.010_bib21","doi-asserted-by":"crossref","first-page":"4056","DOI":"10.1038\/s41467-019-12028-5","article-title":"CRISPR-Cas9-based mutagenesis frequently provokes on-target mRNA misregulation","volume":"10","author":"Tuladhar","year":"2019","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.biochi.2026.09.010_bib22","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-49297-5","article-title":"Overexpression and alternative splicing of NF-YA in breast cancer","volume":"9","author":"Dolfini","year":"2019","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.biochi.2026.09.010_bib23","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1038\/s42003-023-04987-9","article-title":"NFYA promotes malignant behavior of triple-negative breast cancer in mice through the regulation of lipid metabolism","volume":"6","author":"Okada","year":"2023","journal-title":"Commun. Biol."},{"issue":"5","key":"10.1016\/j.biochi.2026.09.010_bib24","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.bbagrm.2016.12.005","article-title":"NF-Y in cancer: impact on cell transformation of a gene essential for proliferation","volume":"1860","author":"Gurtner","year":"2017","journal-title":"Biochim. Biophys. Acta, Gene Regul. Mech."},{"issue":"8","key":"10.1016\/j.biochi.2026.09.010_bib25","first-page":"2168","article-title":"Cell cycle-mediated drug resistance: an emerging concept in cancer therapy","volume":"7","author":"Shah","year":"2001","journal-title":"Clin. Cancer Res."}],"container-title":["Biochimie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300908426002294?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300908426002294?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T20:02:01Z","timestamp":1790280121000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0300908426002294"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":25,"alternative-id":["S0300908426002294"],"URL":"https:\/\/doi.org\/10.1016\/j.biochi.2026.09.010","relation":{},"ISSN":["0300-9084"],"issn-type":[{"value":"0300-9084","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"NFYA regulates the expression of CD44 via binding to upstream cis-element in breast cancer cells","name":"articletitle","label":"Article Title"},{"value":"Biochimie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biochi.2026.09.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. and Soci\u00e9t\u00e9 Fran\u00e7aise de Biochimie et Biologie Mol\u00e9culaire (SFBBM). All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}